 | • レポートコード：MRC2102QY12114 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の組換えヒトエンドスタチン市場について種類別（純度：95％、その他）、用途別（医療、科学研究、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・組換えヒトエンドスタチン市場の概要 ・世界の主要地域別組換えヒトエンドスタチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の組換えヒトエンドスタチン市場規模2015-2026：種類別（純度：95％、その他） ・世界の組換えヒトエンドスタチン市場規模2015-2026：用途別（医療、科学研究、その他） ・組換えヒトエンドスタチンの米国市場規模2015-2020 ・組換えヒトエンドスタチンのヨーロッパ市場規模2015-2020 ・組換えヒトエンドスタチンの中国市場規模2015-2020 ・組換えヒトエンドスタチンの日本市場規模2015-2020 ・組換えヒトエンドスタチンの東南アジア市場規模2015-2020 ・組換えヒトエンドスタチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・組換えヒトエンドスタチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・組換えヒトエンドスタチンの市場動向・機会・課題 ・調査の結論 |
Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294.
Market Analysis and Insights: Global Recombinant Human Endostatin Market
The global Recombinant Human Endostatin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Recombinant Human Endostatin Scope and Market Size
The global Recombinant Human Endostatin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Human Endostatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Recombinant Human Endostatin market is segmented into
Purity:95%
Others
Segment by Application, the Recombinant Human Endostatin market is segmented into
Medical Care
Scientific Research
Others
The Recombinant Human Endostatin market is analysed and market size information is provided by regions (countries). Segment by Application, the Recombinant Human Endostatin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Recombinant Human Endostatin Market Share Analysis
Recombinant Human Endostatin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Recombinant Human Endostatin business, the date to enter into the Recombinant Human Endostatin market, Recombinant Human Endostatin product introduction, recent developments, etc.
The major vendors covered:
Thermo Fisher Scientific
PeproTech
1 Recombinant Human Endostatin Market Overview
1.1 Recombinant Human Endostatin Product Scope
1.2 Recombinant Human Endostatin Segment by Type
1.2.1 Global Recombinant Human Endostatin Sales by Type (2020-2026)
1.2.2 Purity:95%
1.2.3 Others
1.3 Recombinant Human Endostatin Segment by Application
1.3.1 Global Recombinant Human Endostatin Sales Comparison by Application (2020-2026)
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 Recombinant Human Endostatin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Recombinant Human Endostatin Sales Growth Rate (2015-2026)
1.4.2 Global Recombinant Human Endostatin Revenue and Growth Rate (2015-2026)
1.4.3 Global Recombinant Human Endostatin Price Trends (2015-2026)
2 Recombinant Human Endostatin Estimate and Forecast by Region
2.1 Global Recombinant Human Endostatin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Recombinant Human Endostatin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Recombinant Human Endostatin Sales Market Share by Region (2015-2020)
2.2.2 Global Recombinant Human Endostatin Revenue Market Share by Region (2015-2020)
2.3 Global Recombinant Human Endostatin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Recombinant Human Endostatin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Recombinant Human Endostatin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Recombinant Human Endostatin Estimates and Projections (2015-2026)
2.4.2 Europe Recombinant Human Endostatin Estimates and Projections (2015-2026)
2.4.3 China Recombinant Human Endostatin Estimates and Projections (2015-2026)
2.4.4 Japan Recombinant Human Endostatin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Recombinant Human Endostatin Estimates and Projections (2015-2026)
2.4.6 India Recombinant Human Endostatin Estimates and Projections (2015-2026)
3 Global Recombinant Human Endostatin Competition Landscape by Players
3.1 Global Top Recombinant Human Endostatin Players by Sales (2015-2020)
3.2 Global Top Recombinant Human Endostatin Players by Revenue (2015-2020)
3.3 Global Recombinant Human Endostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Endostatin as of 2019)
3.4 Global Recombinant Human Endostatin Average Price by Company (2015-2020)
3.5 Manufacturers Recombinant Human Endostatin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Recombinant Human Endostatin Players (Opinion Leaders)
4 Global Recombinant Human Endostatin Market Size by Type
4.1 Global Recombinant Human Endostatin Historic Market Review by Type (2015-2020)
4.1.1 Global Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
4.1.2 Global Recombinant Human Endostatin Revenue Market Share by Type (2015-2020)
4.1.3 Global Recombinant Human Endostatin Price by Type (2015-2020)
4.2 Global Recombinant Human Endostatin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Recombinant Human Endostatin Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Human Endostatin Revenue Forecast by Type (2021-2026)
4.2.3 Global Recombinant Human Endostatin Price Forecast by Type (2021-2026)
5 Global Recombinant Human Endostatin Market Size by Application
5.1 Global Recombinant Human Endostatin Historic Market Review by Application (2015-2020)
5.1.1 Global Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
5.1.2 Global Recombinant Human Endostatin Revenue Market Share by Application (2015-2020)
5.1.3 Global Recombinant Human Endostatin Price by Application (2015-2020)
5.2 Global Recombinant Human Endostatin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Recombinant Human Endostatin Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Human Endostatin Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Human Endostatin Price Forecast by Application (2021-2026)
6 United States Recombinant Human Endostatin Market Facts & Figures
6.1 United States Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
6.2 United States Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
6.3 United States Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
7 Europe Recombinant Human Endostatin Market Facts & Figures
7.1 Europe Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
7.2 Europe Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
7.3 Europe Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
8 China Recombinant Human Endostatin Market Facts & Figures
8.1 China Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
8.2 China Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
8.3 China Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
9 Japan Recombinant Human Endostatin Market Facts & Figures
9.1 Japan Recombinant Human Endostatin Sales Market Share by Company (3015-3030)
9.2 Japan Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
9.3 Japan Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
10 Southeast Asia Recombinant Human Endostatin Market Facts & Figures
10.1 Southeast Asia Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
11 India Recombinant Human Endostatin Market Facts & Figures
11.1 India Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
11.2 India Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
11.3 India Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Recombinant Human Endostatin Business
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Corporation Information
12.1.2 Thermo Fisher Scientific Business Overview
12.1.3 Thermo Fisher Scientific Recombinant Human Endostatin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Thermo Fisher Scientific Recombinant Human Endostatin Products Offered
12.1.5 Thermo Fisher Scientific Recent Development
12.2 PeproTech
12.2.1 PeproTech Corporation Information
12.2.2 PeproTech Business Overview
12.2.3 PeproTech Recombinant Human Endostatin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 PeproTech Recombinant Human Endostatin Products Offered
12.2.5 PeproTech Recent Development
…
13 Recombinant Human Endostatin Manufacturing Cost Analysis
13.1 Recombinant Human Endostatin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Recombinant Human Endostatin
13.4 Recombinant Human Endostatin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Recombinant Human Endostatin Distributors List
14.3 Recombinant Human Endostatin Customers
15 Market Dynamics
15.1 Recombinant Human Endostatin Market Trends
15.2 Recombinant Human Endostatin Opportunities and Drivers
15.3 Recombinant Human Endostatin Market Challenges
15.4 Recombinant Human Endostatin Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Recombinant Human Endostatin Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Recombinant Human Endostatin Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Recombinant Human Endostatin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Recombinant Human Endostatin Sales (MT) by Region (2015-2020)
Table 5. Global Recombinant Human Endostatin Sales Market Share by Region (2015-2020)
Table 6. Global Recombinant Human Endostatin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Recombinant Human Endostatin Revenue Share by Region (2015-2020)
Table 8. Global Recombinant Human Endostatin Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Recombinant Human Endostatin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Recombinant Human Endostatin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Recombinant Human Endostatin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Recombinant Human Endostatin (MT) of Key Companies (2015-2020)
Table 13. Global Recombinant Human Endostatin Sales Share by Company (2015-2020)
Table 14. Global Recombinant Human Endostatin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Recombinant Human Endostatin Revenue Share by Company (2015-2020)
Table 16. Global Recombinant Human Endostatin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Endostatin as of 2019)
Table 17. Global Recombinant Human Endostatin Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Recombinant Human Endostatin Manufacturing Sites and Area Served
Table 19. Manufacturers Recombinant Human Endostatin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Recombinant Human Endostatin Players
Table 22. Global Recombinant Human Endostatin Sales (MT) by Type (2015-2020)
Table 23. Global Recombinant Human Endostatin Sales Share by Type (2015-2020)
Table 24. Global Recombinant Human Endostatin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Recombinant Human Endostatin Price (MT) by Type (2015-2020)
Table 26. Global Recombinant Human Endostatin Sales Share by Type (2021-2026)
Table 27. Global Recombinant Human Endostatin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Recombinant Human Endostatin Revenue Share by Type (2021-2026)
Table 29. Global Recombinant Human Endostatin Price (MT) by Type (2021-2026)
Table 30. Global Recombinant Human Endostatin Sales (MT) by Application (2015-2020)
Table 31. Global Recombinant Human Endostatin Sales Share by Application (2015-2020)
Table 32. Global Recombinant Human Endostatin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Recombinant Human Endostatin Price (MT) by Application (2015-2020)
Table 34. Global Recombinant Human Endostatin Sales (MT) by Application (2021-2026)
Table 35. Global Recombinant Human Endostatin Sales Share by Application (2021-2026)
Table 36. Global Recombinant Human Endostatin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Recombinant Human Endostatin Revenue Share by Application (2021-2026)
Table 38. Global Recombinant Human Endostatin Price (MT) by Application (2021-2026)
Table 39. United States Recombinant Human Endostatin Sales (MT) by Company (2015-2020)
Table 40. United States Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
Table 41. United States Recombinant Human Endostatin Sales (MT) by Type (2015-2020)
Table 42. United States Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
Table 43. United States Recombinant Human Endostatin Sales (MT) by Application (2015-2020)
Table 44. United States Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
Table 45. Europe Recombinant Human Endostatin Sales (MT) by Company (2015-2020)
Table 46. Europe Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
Table 47. Europe Recombinant Human Endostatin Sales (MT) by Type (2015-2020)
Table 48. Europe Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
Table 49. Europe Recombinant Human Endostatin Sales (MT) by Application (2015-2020)
Table 50. Europe Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
Table 51. China Recombinant Human Endostatin Sales (MT) by Company (2015-2020)
Table 52. China Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
Table 53. China Recombinant Human Endostatin Sales (MT) by Type (2015-2020)
Table 54. China Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
Table 55. China Recombinant Human Endostatin Sales (MT) by Application (2015-2020)
Table 56. China Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
Table 57. Japan Recombinant Human Endostatin Sales (MT) by Company (2015-2020)
Table 58. Japan Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
Table 59. Japan Recombinant Human Endostatin Sales (MT) by Type (2015-2020)
Table 60. Japan Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
Table 61. Japan Recombinant Human Endostatin Sales (MT) by Application (2015-2020)
Table 62. Japan Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Recombinant Human Endostatin Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Recombinant Human Endostatin Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Recombinant Human Endostatin Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
Table 69. India Recombinant Human Endostatin Sales (MT) by Company (2015-2020)
Table 70. India Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
Table 71. India Recombinant Human Endostatin Sales (MT) by Type (2015-2020)
Table 72. India Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
Table 73. India Recombinant Human Endostatin Sales (MT) by Application (2015-2020)
Table 74. India Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
Table 75. Thermo Fisher Scientific Corporation Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific Recombinant Human Endostatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Thermo Fisher Scientific Recombinant Human Endostatin Product
Table 79. Thermo Fisher Scientific Recent Development
Table 80. PeproTech Corporation Information
Table 81. PeproTech Description and Business Overview
Table 82. PeproTech Recombinant Human Endostatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. PeproTech Recombinant Human Endostatin Product
Table 84. PeproTech Recent Development
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Recombinant Human Endostatin Distributors List
Table 88. Recombinant Human Endostatin Customers List
Table 89. Recombinant Human Endostatin Market Key Trends
Table 90. Recombinant Human Endostatin Key Opportunities and Drivers
Table 91. Recombinant Human Endostatin Market Challenges
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Endostatin Product Picture
Figure 2. Global Recombinant Human Endostatin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Recombinant Human Endostatin Market Share by Application in 2020 & 2026
Figure 6. Medical Care Examples
Figure 7. Scientific Research Examples
Figure 8. Others Examples
Figure 9. Global Recombinant Human Endostatin Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Recombinant Human Endostatin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Recombinant Human Endostatin Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Recombinant Human Endostatin Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Recombinant Human Endostatin Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Recombinant Human Endostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Recombinant Human Endostatin Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Recombinant Human Endostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Recombinant Human Endostatin Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Recombinant Human Endostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Recombinant Human Endostatin Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Recombinant Human Endostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Recombinant Human Endostatin Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Recombinant Human Endostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Recombinant Human Endostatin Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Recombinant Human Endostatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Recombinant Human Endostatin Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Recombinant Human Endostatin Players Market Share by Revenue in Recombinant Human Endostatin 2015 & 2019
Figure 27. Recombinant Human Endostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Recombinant Human Endostatin Revenue Share by Type (2015-2020)
Figure 29. Global Recombinant Human Endostatin Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Recombinant Human Endostatin Revenue Share by Application (2015-2020)
Figure 31. Global Recombinant Human Endostatin Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Recombinant Human Endostatin Sales Market Share by Type in 2019
Figure 33. United States Recombinant Human Endostatin Sales Market Share by Type in 2019
Figure 34. Europe Recombinant Human Endostatin Sales Market Share by Company in 2019
Figure 35. Europe Recombinant Human Endostatin Sales Market Share by Type in 2019
Figure 36. Europe Recombinant Human Endostatin Sales Market Share by Application in 2019
Figure 37. China Recombinant Human Endostatin Sales Market Share by Company in 2019
Figure 38. China Recombinant Human Endostatin Sales Market Share by Type in 2019
Figure 39. China Recombinant Human Endostatin Sales Market Share by Application in 2019
Figure 40. Japan Recombinant Human Endostatin Sales Market Share by Company in 2019
Figure 41. Japan Recombinant Human Endostatin Sales Market Share by Type in 2019
Figure 42. Japan Recombinant Human Endostatin Sales Market Share by Application in 2019
Figure 43. Southeast Asia Recombinant Human Endostatin Sales Market Share by Company in 2019
Figure 44. Southeast Asia Recombinant Human Endostatin Sales Market Share by Type in 2019
Figure 45. Southeast Asia Recombinant Human Endostatin Sales Market Share by Application in 2019
Figure 46. India Recombinant Human Endostatin Sales Market Share by Company in 2019
Figure 47. India Recombinant Human Endostatin Sales Market Share by Type in 2019
Figure 48. India Recombinant Human Endostatin Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Recombinant Human Endostatin
Figure 51. Manufacturing Process Analysis of Recombinant Human Endostatin
Figure 52. Recombinant Human Endostatin Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
ヒトエンドスタチンの世界市場レポート2020 Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294. Market Analysis and Insights: Global Human Endostatin Market The global Human Endostatin marke…- 組換えヒト血清アルブミンの世界市場レポート2020 Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression syste…
- 治療用組換えタンパク質の世界市場レポート2020 Recombinant Therapeutic Protein are produced by using a technique called recombinant DNA or recombinant RNA to produce proteins. The method can be divided into in vitro method and in vivo method. Both approaches are premised on the use of genetic recombination techniques to obtain recombinant vector…
- 組換えトリプシンの世界市場レポート2020 Market Analysis and Insights: Global Recombinant Trypsin Market The global Recombinant Trypsin market size is projected to reach US$ 44 million by 2026, from US$ 27 million in 2020, at a CAGR of 8.2% during 2021-2026. Global Recombinant Trypsin Scope and Market Size The global Recombinant Trypsin ma…
- ヒト凝固因子VIIの世界市場レポート2020 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…